Jan Anders Holgersson
Gründer bei NovaHep AB
Aktive Positionen von Jan Anders Holgersson
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Karolinska Institutet | Corporate Officer/Principal | - | - |
NovaHep AB
 NovaHep AB Miscellaneous Commercial ServicesCommercial Services NovaHep AB provides stem-cell research for gene therapy of liver diseases. Its main area of focus is the development of biological, individualised blood vessels that can be used to replace non-functioning blood vessels in patients with different types of vascular disease. The company was founded by Suchitra Sumitran-Holgersson and Jan Anders Holgersson in 2005 and is headquartered in Gothenburg, Sweden. | Vorsitzender | 01.01.2005 | - |
| Gründer | 26.11.2009 | - | |
| Direktor/Vorstandsmitglied | 01.01.2005 | - | |
| Technik-/Wissenschafts-/F&E-Leiter | 01.01.2005 | - | |
| University of Gothenburg | Corporate Officer/Principal | - | - |
Karriereverlauf von Jan Anders Holgersson
Ehemalige bekannte Positionen von Jan Anders Holgersson
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
Recopharma AB
 Recopharma AB Pharmaceuticals: MajorHealth Technology Recopharma AB is a biotechnology company that develops ophthalmic products based on protein-carbohydrate interactions. It develops a technology that uses mucins, naturally occurring proteins produced by epithelial tissues with many potential applications. The company was founded in 2004 and is headquartered in Huddinge, Sweden | Direktor/Vorstandsmitglied | 25.11.2009 | - |
| Vorstandsvorsitzender | 01.01.2004 | - | |
| Technik-/Wissenschafts-/F&E-Leiter | 01.01.2004 | - | |
| Gründer | 25.11.2009 | - | |
AbSorber AB
 AbSorber AB Medical SpecialtiesHealth Technology AbSorber AB develops products for allogeneic transplantation. It offers XM-ONE used for enhanced risk assessment before kidney transplantation. The firm also engages in the development of tools in transplantation. The company was founded by Jan Holgersson and Suchitra Sumitran-Holgersson in 1999 and is headquartered in Stockholm, Sweden. | Direktor/Vorstandsmitglied | 01.01.1999 | - |
| Gründer | 01.01.1999 | - |
Ausbildung von Jan Anders Holgersson
| University of Gothenburg | Doctorate Degree |
Statistik
International
| Schweden | 6 |
Operativ
| Director/Board Member | 3 |
| Founder | 3 |
| Chief Tech/Sci/R&D Officer | 2 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Commercial Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Private Unternehmen | 3 |
|---|---|
AbSorber AB
AbSorber AB Medical SpecialtiesHealth Technology AbSorber AB develops products for allogeneic transplantation. It offers XM-ONE used for enhanced risk assessment before kidney transplantation. The firm also engages in the development of tools in transplantation. The company was founded by Jan Holgersson and Suchitra Sumitran-Holgersson in 1999 and is headquartered in Stockholm, Sweden. | Health Technology |
Recopharma AB
Recopharma AB Pharmaceuticals: MajorHealth Technology Recopharma AB is a biotechnology company that develops ophthalmic products based on protein-carbohydrate interactions. It develops a technology that uses mucins, naturally occurring proteins produced by epithelial tissues with many potential applications. The company was founded in 2004 and is headquartered in Huddinge, Sweden | Health Technology |
NovaHep AB
NovaHep AB Miscellaneous Commercial ServicesCommercial Services NovaHep AB provides stem-cell research for gene therapy of liver diseases. Its main area of focus is the development of biological, individualised blood vessels that can be used to replace non-functioning blood vessels in patients with different types of vascular disease. The company was founded by Suchitra Sumitran-Holgersson and Jan Anders Holgersson in 2005 and is headquartered in Gothenburg, Sweden. | Commercial Services |
- Börse
- Insiders
- Jan Anders Holgersson
- Erfahrung